Evaluating anticancer activity of emodin by enhancing antioxidant activities and affecting PKC/ADAMTS4 pathway in thioacetamide-induced hepatocellular carcinoma in rats-Reference-Cited by-同舟云学术

Evaluating anticancer activity of emodin by enhancing antioxidant activities and affecting PKC/ADAMTS4 pathway in thioacetamide-induced hepatocellular carcinoma in rats

Published:2024-06-11 Issue:1 Volume:29 Page:
ISSN:1351-0002
Container-title:Redox Report
language:en
Short-container-title:Redox Report

Author:

Hassan Hanan M.¹,Hamdan Ahmed M.²,Alattar Abdullah³,Alshaman Reem³,Bahattab Omar⁴,Al-Gayyar Mohammed M. H.⁵⁶^ORCID

Affiliation:

1. Dept. of Pharmacology and Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt

2. Department of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia

3. Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia

4. Department of Biology, Faculty of Science, University of Tabuk, Tabuk, Saudi Arabia

5. Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt

6. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13510002.2024.2365590

Reference53 articles.

1. Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management

2. Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers

3. Tumor microenvironment of hepatocellular carcinoma: challenges and opportunities for New treatment options;Sas Z;Int J Mol Sci,2022

4. Outcomes and toxicities of modern combined modality therapy with atezolizumab plus bevacizumab and radiation therapy for hepatocellular carcinoma;Manzar GS;Cancers (Basel),2022

5. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods